Skip to main content
Go Back to System Level

View clinical trials for the following:

Central Nervous System Cancer Clinical Trials

Coordinator: Megan Camara | 410-369-5355

NRG BN012 | A Randomized Phase III Trial of Pre-Operative Compared to Post-Operative Stereotactic Radiosurgery in Patients With Resectable Brain Metastases

Principal Investigator: Mark Mishra, MD

Sites:

  • University of Maryland Medical Center
  • Maryland Proton Treatment Center

Learn More: Find contact and eligibility information for this clinical trial.

GCC 19140 | Pilot Study of Laser Interstitial Thermal Therapy Followed By Hypofractionated Radiation Therapy For Recurrent Gliomas

Principal Investigator: Mark Mishra, MD

Sites:

  • University of Maryland Medical Center
  • Central Maryland Radiation Oncology
  • University of Maryland Baltimore Washington Medical Center
  • Maryland Proton Treatment Center
  • University of Maryland Upper Chesapeake Health

Learn More: Find contact and eligibility information for this clinical trial.

GCC 20138 | Laser Interstitial Thermal Therapy Followed By Hypofractionated Radiation Therapy For Treatment of Newly Diagnosed High-Grade Gliomas

Principal Investigator: Mark Mishra, MD

Sites:

  • University of Maryland Medical Center
  • Maryland Proton Treatment Center

Learn More: Find contact and eligibility information for this clinical trial.

NRG BN009 | Phase III Trial of Salvage Stereotactic Radiosurgery (SRS) or SRS + Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) For First or Second Distant Brain Relapse After Upfront SRS With Brain Metastasis Velocity ≥4 Brain Metastases/Year

Principal Investigator: Mark Mishra, MD

Sites:

  • University of Maryland Medical Center
  • University of Maryland Baltimore Washington Medical Center
  • Central Maryland Radiation Oncology
  • University of Maryland Upper Chesapeake Health

Learn More: Find contact and eligibility information for this clinical trial.

NRG BN011 | A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma

Principal Investigator: Mark Mishra, MD

Sites:

  • University of Maryland Medical Center
  • University of Maryland Baltimore Washington Medical Center
  • Central Maryland Radiation Oncology

Learn More: Find contact and eligibility information for this clinical trial.

NRG CC009 | Phase III Trial of Stereotactic Radiosurgery (SRS) versus Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for 10 or fewer Brain Metastases from Small Cell Lung Cancer

Principal Investigator: Mark Mishra, MD

Sites:

  • University of Maryland Medical Center
  • University of Maryland Baltimore Washington Medical Center
  • Central Maryland Radiation Oncology
  • University of Maryland Shore Regional Health

Learn More: Find contact and eligibility information for this clinical trial.

Head and Neck Cancer Clinical Trials

Coordinator: Kelly Kitzmiller | 410-369-5264

EA3191 | A Phase II Randomized Trial of Adjuvant Therapy with Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma with High Risk Features

Principal Investigator: Matthew Ferris, MD

Sites:

  • University of Maryland Medical Center
  • University of Maryland Baltimore Washington Medical Center
  • Central Maryland Radiation Oncology
  • University of Maryland Upper Chesapeake Health
  • Maryland Proton Treatment Center

Learn More: Find contact and eligibility information for this clinical trial. 

RTOG 1216 | Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Principal Investigator: Matthew Ferris, MD

Sites:

  • University of Maryland Medical Center
  • University of Maryland Baltimore Washington Medical Center
  • Central Maryland Radiation Oncology
  • University of Maryland Upper Chesapeake Health

Learn More: Find contact and eligibility information for this clinical trial. 

NRG HN009 | Randomized Phase II/III Trial of Radiation with High-Dose Cisplatin (100 mg/m2) Every Three Weeks Versus Radiation with Low-Dose Weekly Cisplatin (40 mg/m2) for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Principal Investigator: Matthew Ferris, MD

Sites:

  • University of Maryland Medical Center
  • University of Maryland Baltimore Washington Medical Center
  • Central Maryland Radiation Oncology
  • Maryland Proton Treatment Center

Learn More: Find contact and eligibility information for this clinical trial.

Find more head and neck cancer clinical trials at UMGCCC.

GCC 2380 | A Single Arm Phase II Trial Evaluating Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL) 

Principal Investigator: Jason Molitoris, MD, PhD

Sites:

  • University of Maryland Medical Center
  • Maryland Proton Treatment Center

Learn More: Find contact and eligibility information for this clinical trial.

Breast Cancer Clinical Trials

Coordinator: Caitlin Eggleston | 410-328-7586

NRG BR008 | Testing the usual treatment of radiation therapy and HER2-targeted therapy toHER2-targeted therapy alone for low-risk HER2-positive breast cancer

Principal Investigator: Rashmi Benda, MD

Sites:

  • University of Maryland Medical Center
  • Baltimore Washington Medical Center
  • Central Maryland Radiation Oncology
  • University of Maryland Shore Regional Health
  • University of Maryland Upper Chesapeake Health

Learn More: Find contact and eligibility information for this clinical trial.

GenterCC 1570 PCG BRE007 | Phase II protocol of proton therapy for partial breast irradiation in early stage breast cancer

Principal Investigator: Elizabeth Nichols, MD

Sites:

  • Maryland Proton Treatment Center

Learn More: Find contact and eligibility information for this clinical trial. 

NRG BR007 | A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER2-Negative, Oncotype Recurrence Score (DEBRA)

Principal Investigator: Sarah McAvoy, MD

Sites:

  • University of Maryland Medical Center
  • Central Maryland Radiation Oncology
  • University of Maryland Baltimore Washington Medical Center
  • University of Maryland Upper Chesapeake Health
  • University of Maryland Shore Regional Health

Learn More: Find contact and eligibility information for this clinical trial.

CCTG MA.39 | Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive and T3N0 Breast Cancer

Principal Investigator: Sarah McAvoy, MD

Sites:

  • University of Maryland Medical Center
  • Central Maryland Radiation Oncology
  • University of Maryland Baltimore Washington Medical Center
  • University of Maryland Upper Chesapeake Health
  • University of Maryland Shore Regional Health

Learn More: Find contact and eligibility information for this clinical trial.

GammaPod Studies

GCC 1876 | Tumor Bed Boost using a Breast Specific Radiosurgery Device, The GammaPodTM: Registry Study and Evaluation of Quality of Life with Development of Sizing Nomogram; PI: Nichols

Principal Investigator: Elizabeth Nichols, MD

Sites:

  • University of Maryland Medical Center
  • University of Maryland Baltimore Washington Medical Center
  • Central Maryland Radiation Oncology
  • University of Maryland Upper Chesapeake Health

Learn More: Find contact and eligibility information for this clinical trial.

GCC 1926 | A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast S-PBI for Early Stage Breast Cancer

Principal Investigator: Elizabeth Nichols, MD

Sites:

  • University of Maryland Medical Center, Referral from:
    • University of Maryland Baltimore Washington Medical Center
    • University of Maryland Upper Chesapeake Health
    • Central Maryland Radiation Oncology

Learn More: Find contact and eligibility information for this clinical trial.

Lung Cancer Clinical Trials

Coordinator: Caitlin Eggleston | 410-328-7586

S1827 | MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)

Principal Investigator: Matthew Ferris, MD

Sites:

  • University of Maryland Medical Center
  • University of Maryland Upper Chesapeake Health
  • Central Maryland Radiation Oncology
  • University of Maryland Baltimore Washington Medical Center

Learn More: Find contact and eligibility information for this clinical trial.  

GI Cancer Clinical Trials

Coordinator: Caitlin Eggleston | 410-328-7586 

GCC 1886 | Phase I Study of Concurrent Nab-Paclitaxel + Gemcitabine with Hypofractionated, Ablative Proton Therapy for Locally Advanced Pancreatic Cancer

Principal Investigator: Jason Molitoris, MD, PhD

Sites:

  • University of Maryland Medical Center
  • Maryland Proton Treatment Center

Learn More: Find contact and eligibility information for this clinical trial.

GCC 2242 | Hybrid Virtual MRI/CBCT for Image Guidance in Liver Radiation Therapy

Principal Investigator: Lei Ren, PhD

Sites:

  • University of Maryland Baltimore Washington Medical Center
  • Maryland Proton Treatment Center

Genitourinary and Gynecological Cancer Clinical Trials

Coordinator: Caitlin Eggleston | 410-328-7586

GCC 1944 | A Randomized Phase III Trial of Two Standard Dose Fractionation Regimens for Adjuvant Vaginal Brachytherapy in Early Stage Endometrial Cancer

Principal Investigator: Sarah McAvoy, MD

Sites:

  • University of Maryland Medical Center
  • University of Maryland Upper Chesapeake Health
  • Central Maryland Radiation Oncology

Learn More: Find contact and eligibility information for this clinical trial. 

Prostate Cancer Clinical Trials

Coordinator: Acara Carter | 410-369-5350 

GCC 2032 | Phase 1 Feasibility Study of Strength Training with Androgen Deprivation and Proton Therapy for Intermediate and High Risk Prostate Cancer

Principal Investigator: Matthew Ferris, MD

Sites:

  • Maryland Proton Treatment Center

GCC 2048 | A Phase I Dose Escalation Study of Hypofractionated Accelerated Pelvic Nodal Radiotherapy Delivered With A Simultaneously Integrated Prostate Boost For Patients With Localized, Intermediate- And High-Risk Prostate Cancer

Principal Investigator: Mark Mishra, MD

Sites:

  • Maryland Proton Treatment Center

Learn More: Find contact and eligibility information for this clinical trial. 

GCC 21136 | Phase 2 randomized Total Eradication of metastatic lesions following definitive Radiation to the Prostate in de novo oligometastatic prostate cancer (TERPS) trial

Principal Investigator: Phuoc Tho Tran, MD

Sites:

  • University of Maryland Baltimore Washington Medical Center
  • Maryland Proton Treatment Center
  • University of Maryland Medical Center
  • Central Maryland Radiation Oncology

Learn More: Find contact and eligibility information for this clinical trial.

NRG GU009 | Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (Predict-RT*) *Prostate RNA Expression/Decipher to Individualize Concurrent Therapy with Radiation trial

Principal Investigator: Zaker Hamid Rana, MD

Sites:

  • University of Maryland Baltimore Washington Medical Center
  • Maryland Proton Treatment Center
  • Upper Chesapeake Medical Center
  • University of Maryland Medical Center
  • Central Maryland Radiation Oncology

Learn More: Find contact and eligibility information for this clinical trial.

NRG GU010 | Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (Guidance)

Principal Investigator: Zaker Hamid Rana, MD

Sites:

  • University of Maryland Baltimore Washington Medical Center
  • Maryland Proton Treatment Center
  • Upper Chesapeake Medical Center
  • University of Maryland Medical Center
  • Central Maryland Radiation Oncology

Learn More: Find contact and eligibility information for this clinical trial.

GCC 23100 | A Randomized Trial of High-risK metachroNous oligometastatIc Prostate Cancer With hiGh-risk Mutations Treated witH meTastasiS Directed Therapy and Niraparib/Abiraterone Acetate and Prednisone (KNIGHTS)

Principal Investigator: Jason Molitoris, MD, PhD

Sites:

  • University of Maryland Medical Center
  • Maryland Proton Treatment Center

Learn More: Find contact and eligibility information for this clinical trial.

Pediatric Cancer Clinical Trials

Coordinator: Caitlin Eggleston | 410-328-7586

GCC 1669 | Pediatric Proton Consortium Registry: Registry for pediatric patients treated with proton RT

Principal Investigator: Young Kwok, MD

Sites:

  • Maryland Proton Treatment Center

Learn More: Find contact and eligibility information for this clinical trial.

Other Radiation Oncology Clinical Trials

Contact MPTC Research Office at 410-369-5226

GCC 2384 | Evaluation of Improved Onboard Patient Imaging with the Varian HyperSight Platform on TrueBeam 4.1

Principal Investigator: Jason Molitoris, MD, PhD

Sites:

  • University of Maryland medical Center

Learn More: Find contact and eligibility information for this clinical trial.

GCC 1552 | PCG Registry | Evaluation Tracking Project: A Prospective Chart Review of Patients Treated with Radiation Therapy

Principal Investigator: Mark Mishra, MD

Sites:

  • Maryland Proton Treatment Center

Learn More: Find contact and eligibility information for this clinical trial.

In This Section:

A best hospitals badge from U.S. News & World Report awarded to UMMC for cancer.
NCI Designated Comprehensive Cancer Center badge